Angela Mariotto: Difference between revisions
Content deleted Content added
Victuallers (talk | contribs) →Life: <ref name=forexample> |
→Education: Adding/improving reference(s) |
||
| (4 intermediate revisions by 4 users not shown) | |||
| Line 1: | Line 1: | ||
{{Short description|Statistician}} |
|||
{{Infobox scientist |
{{Infobox scientist |
||
| name = Angela Mariotto |
| name = Angela Mariotto |
||
| Line 15: | Line 16: | ||
'''Angela Bacelar Mariotto''' is a statistician who researches the development and improvement of cancer progress measures. She is chief of the [[Data analysis|data analytics]] branch at the [[National Cancer Institute]]. Mariotto was a researcher at the [[Istituto Superiore di Sanità]]. |
'''Angela Bacelar Mariotto''' is a statistician who researches the development and improvement of cancer progress measures. She is chief of the [[Data analysis|data analytics]] branch at the [[National Cancer Institute]]. Mariotto was a researcher at the [[Istituto Superiore di Sanità]]. |
||
== |
== Education == |
||
Mariotto received her Doctor of Philosophy in Statistics from the [[Imperial College London]].<ref name=":0" /> Her 1988 thesis was titled ''Empirical Bayes inference and the linear model''. Mariotto's doctoral advisor was [[David Cox (statistician)|David Cox]].<ref>{{Cite |
Mariotto received her Doctor of Philosophy in Statistics from the [[Imperial College London]].<ref name=":0" /> Her 1988 thesis was titled ''Empirical Bayes inference and the linear model''. Mariotto's doctoral advisor was [[David Cox (statistician)|David Cox]].<ref>{{Cite web|last=Mariotto|first=Angela Bacellar|date=1989|title=Empirical Bayes inference and the linear model|hdl=10044/1/47557 |url=http://spiral.imperial.ac.uk/handle/10044/1/47557}}</ref> |
||
== Career == |
|||
Mariotto worked at the [[Istituto Superiore di Sanità]] for a decade. She joined the [[National Cancer Institute]] (NCI) in November 1999.<ref name=":0" /> Mariotto is the chief of the [[Data analysis|data analytics]] branch (DAB) of the surveillance research program (SRP) within the division of cancer control and population sciences (DCCPS) at NCI. |
Mariotto worked at the [[Istituto Superiore di Sanità]] for a decade. She joined the [[National Cancer Institute]] (NCI) in November 1999.<ref name=":0" /> Mariotto is the chief of the [[Data analysis|data analytics]] branch (DAB) of the surveillance research program (SRP) within the division of cancer control and population sciences (DCCPS) at NCI. |
||
== Works == |
|||
Mariotto's research interests include development and improvement of cancer progress measures, in particular survival, prevalence, [[quality of life]], utilization, and cost measures.<ref name=forexample>{{Cite journal| |
Mariotto's research interests include development and improvement of cancer progress measures, in particular survival, prevalence, [[quality of life]], utilization, and cost measures.<ref name="forexample">{{Cite journal|last1=Mariotto|first1=Angela|last2=Jayasekerea|first2=Jinani|last3=Petkov|first3=Valentina|last4=Schechter|first4=Clyde B|last5=Enewold|first5=Lindsey|last6=Helzlsouer|first6=Kathy J|last7=Feuer|first7=Eric J|last8=Mandelblatt|first8=Jeanne S|date=2019-04-24|title=Expected Monetary Impact of Oncotype DX Score-Concordant Systemic Breast Cancer Therapy Based on the TAILORx Trial|url=https://doi.org/10.1093/jnci/djz068|journal=JNCI: Journal of the National Cancer Institute|volume=112|issue=2|pages=154–160|doi=10.1093/jnci/djz068|issn=0027-8874|pmc=7019096|pmid=31165854}}</ref> Her other areas of expertise include the development and application of models to predict incidence and prevalence from [[Cancer survival rates|cancer survival]] and mortality data, and models for survival projections. |
||
She is the NCI scientific coordinator of the prostate cancer working groups in the Cancer Intervention and Surveillance Network (CISNET) cooperative agreement, for which she coordinates research activities of three grantees who are investigating questions related to the impact of [[Prostate cancer screening|screening]] and treatment interventions on [[prostate cancer]] mortality trends. |
|||
Mariotto is also responsible for developing new prevalence measures and for reporting the new cancer prevalence statistics to the nation each year. At NCI, Mariotto's duties include management of grants, independent research, and service duties, including helping to disseminate cancer statistics to the general public.<ref name=":0">{{Cite web|title=Angela Mariotto|url=https://surveillance.cancer.gov/about/bios/mariottoa.html|access-date=2021-10-02|website=surveillance.cancer.gov}}{{PD-notice}}</ref> |
|||
== References == |
== References == |
||
| Line 32: | Line 39: | ||
{{Authority control}} |
{{Authority control}} |
||
{{DEFAULTSORT:Mariotto, Angela}} |
{{DEFAULTSORT:Mariotto, Angela}} |
||
[[Category:Living people]] |
[[Category:Living people]] |
||
Latest revision as of 05:08, 29 June 2024
Angela Mariotto | |
|---|---|
 Mariotto in 2017 | |
| Born | Angela Bacelar Mariotto |
| Alma mater | Imperial College London |
| Scientific career | |
| Fields | Statistics |
| Institutions | Istituto Superiore di Sanità National Cancer Institute |
| Thesis | Empirical Bayes inference and the linear model (1989) |
| Doctoral advisor | David Cox |
Angela Bacelar Mariotto is a statistician who researches the development and improvement of cancer progress measures. She is chief of the data analytics branch at the National Cancer Institute. Mariotto was a researcher at the Istituto Superiore di Sanità.
Education
[edit]Mariotto received her Doctor of Philosophy in Statistics from the Imperial College London.[1] Her 1988 thesis was titled Empirical Bayes inference and the linear model. Mariotto's doctoral advisor was David Cox.[2]
Career
[edit]Mariotto worked at the Istituto Superiore di Sanità for a decade. She joined the National Cancer Institute (NCI) in November 1999.[1] Mariotto is the chief of the data analytics branch (DAB) of the surveillance research program (SRP) within the division of cancer control and population sciences (DCCPS) at NCI.
Works
[edit]Mariotto's research interests include development and improvement of cancer progress measures, in particular survival, prevalence, quality of life, utilization, and cost measures.[3] Her other areas of expertise include the development and application of models to predict incidence and prevalence from cancer survival and mortality data, and models for survival projections.
She is the NCI scientific coordinator of the prostate cancer working groups in the Cancer Intervention and Surveillance Network (CISNET) cooperative agreement, for which she coordinates research activities of three grantees who are investigating questions related to the impact of screening and treatment interventions on prostate cancer mortality trends.
Mariotto is also responsible for developing new prevalence measures and for reporting the new cancer prevalence statistics to the nation each year. At NCI, Mariotto's duties include management of grants, independent research, and service duties, including helping to disseminate cancer statistics to the general public.[1]
References
[edit]- ^ a b c "Angela Mariotto". surveillance.cancer.gov. Retrieved 2021-10-02.
This article incorporates text from this source, which is in the public domain.
- ^ Mariotto, Angela Bacellar (1989). "Empirical Bayes inference and the linear model". hdl:10044/1/47557.
- ^ Mariotto, Angela; Jayasekerea, Jinani; Petkov, Valentina; Schechter, Clyde B; Enewold, Lindsey; Helzlsouer, Kathy J; Feuer, Eric J; Mandelblatt, Jeanne S (2019-04-24). "Expected Monetary Impact of Oncotype DX Score-Concordant Systemic Breast Cancer Therapy Based on the TAILORx Trial". JNCI: Journal of the National Cancer Institute. 112 (2): 154–160. doi:10.1093/jnci/djz068. ISSN 0027-8874. PMC 7019096. PMID 31165854.
This article incorporates public domain material from websites or documents of the National Institutes of Health.External links
[edit]- Angela Mariotto publications indexed by Google Scholar
- Angela Mariotto's publications indexed by the Scopus bibliographic database. (subscription required)
